Prana Biotechnology Receives Notice of Allowance from the US Patent and Trade Mark Office (PBT.AX, 00976861, 20090812)

Huntleys' Stock of the Week

FINANCE NEWS

Other Resources
- RSS Feeds
- Message Boards

Finance Videos

Marketplace

Prana Biotechnology Receives Notice of Allowance from the US Patent and Trade Mark Office
Wednesday August 12, 2009, 2:33 pm

Original Announcement: Prana Allowed Key Patent for PBT2 in the United States

Prana Biotechnology announced that it has received a Notice of Allowance from the United States Patent and Trade Mark Office, protecting its clinical asset, PBT2, in the USA. The patent entitled, 8-Hydroxyquinoline derivatives covers the composition of matter of selected families of 8-Hydroxyquinoline compounds, including PBT2 and pharmaceutical compositions containing these compounds. The USA patent is expected to formally proceed to Grant by December 2009, following payment of official fees. Prana has also secured the Grant of related patents in Russia, Singapore, South Africa, New Zealand and has a Notice of Acceptance in Australia. Previously Prana has announced receiving a notice of Decision to Grant in Europe.

More information about PBT.AX